88 related articles for article (PubMed ID: 22483788)
1. Key players in major and bipolar depression--a retrospective analysis of in vivo imaging studies.
Nikolaus S; Hautzel H; Heinzel A; Müller HW
Behav Brain Res; 2012 Jul; 232(2):358-90. PubMed ID: 22483788
[TBL] [Abstract][Full Text] [Related]
2. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
3. Neural circuits underlying the pathophysiology of mood disorders.
Price JL; Drevets WC
Trends Cogn Sci; 2012 Jan; 16(1):61-71. PubMed ID: 22197477
[TBL] [Abstract][Full Text] [Related]
4. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.
Nikolaus S; Antke C; Beu M; Müller HW
Rev Neurosci; 2010; 21(2):119-39. PubMed ID: 20614802
[TBL] [Abstract][Full Text] [Related]
5. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression.
Lawrence NS; Williams AM; Surguladze S; Giampietro V; Brammer MJ; Andrew C; Frangou S; Ecker C; Phillips ML
Biol Psychiatry; 2004 Mar; 55(6):578-87. PubMed ID: 15013826
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional neuroimaging studies of the suicidal brain.
Desmyter S; van Heeringen C; Audenaert K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):796-808. PubMed ID: 21216267
[TBL] [Abstract][Full Text] [Related]
7. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of dopaminergic and serotonergic dysfunction in manic, depressive and euthymic phases of bipolar disorder.
Nikolaus S; Müller HW; Hautzel H
Nuklearmedizin; 2017; 56(5):191-200. PubMed ID: 29533425
[TBL] [Abstract][Full Text] [Related]
9. Distinct neuronal oscillatory responses between patients with bipolar and unipolar disorders: a magnetoencephalographic study.
Lee PS; Chen YS; Hsieh JC; Su TP; Chen LF
J Affect Disord; 2010 Jun; 123(1-3):270-5. PubMed ID: 19755202
[TBL] [Abstract][Full Text] [Related]
10. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.
Ng WX; Lau IY; Graham S; Sim K
Neurosci Biobehav Rev; 2009 Mar; 33(3):336-54. PubMed ID: 18955079
[TBL] [Abstract][Full Text] [Related]
11. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
[TBL] [Abstract][Full Text] [Related]
12. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
13. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
14. Dissociable functional connectivity changes during the Stroop task relating to risk, resilience and disease expression in bipolar disorder.
Pompei F; Dima D; Rubia K; Kumari V; Frangou S
Neuroimage; 2011 Jul; 57(2):576-82. PubMed ID: 21570470
[TBL] [Abstract][Full Text] [Related]
15. A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder.
Bhardwaj R; Chakrabarti S; Mittal BR; Sharan P
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):334-43. PubMed ID: 20218796
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1A receptor expression in pyramidal neurons of cortical and limbic brain regions.
Palchaudhuri M; Flügge G
Cell Tissue Res; 2005 Aug; 321(2):159-72. PubMed ID: 15947971
[TBL] [Abstract][Full Text] [Related]
17. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
[TBL] [Abstract][Full Text] [Related]
18. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study.
Hasegawa S; Nishi K; Watanabe A; Overstreet DH; Diksic M
Neurochem Int; 2006 Apr; 48(5):358-66. PubMed ID: 16427159
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of abnormal gamma oscillatory activity in unipolar and bipolar disorder patients during an implicit emotion task.
Liu TY; Hsieh JC; Chen YS; Tu PC; Su TP; Chen LF
Neuropsychologia; 2012 Jun; 50(7):1514-20. PubMed ID: 22406691
[TBL] [Abstract][Full Text] [Related]
20. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients.
González A; Fazzino F; Castillo M; Mata S; Lima L
Neuroimmunomodulation; 2007; 14(1):8-15. PubMed ID: 17700035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
